MedTrace Logo

Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils

NCT07639853 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-08-11

No results posted yet for this study

Summary

The purpose of the Case-Specific Health Care Professional (HCP) Clinical Survey for Concerto Versa™ Detachable Coils, also known as the Concerto Versa HCP Clinical Assessment, is to collect early clinical data from HCPs to assess clinical safety and performance of the Concerto Versa™ Detachable Coils, when used in accordance with approved device labeling per the Instructions for Use (IFU). Data collected will generate clinical evidence to quantitatively assess clinical safety and device performance for the purpose of obtaining European Union Medical Device Regulation (EU MDR) approval.

Conditions

  • Arteriovenous Malformation
  • Gastrointestinal Bleed
  • Gastric Varices
  • Hemorrhoid
  • Pelvic Venous Disorders
  • Peripheral Aneurysms
  • Portal Vein Embolization
  • Type II Endoleak
  • Varicocele
  • Hemorrhage

Interventions

DEVICE

Concerto Versa™ Detachable Coils

Concerto Versa™ detachable coil is indicated for arterial and venous embolization in the peripheral vasculature

Sponsors & Collaborators

  • Medtronic Endovascular

    lead INDUSTRY

Principal Investigators

  • John R Laird, Jr, MD · Medtronic Endovascular

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-24
Primary Completion
2026-11-30
Completion
2026-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07639853 on ClinicalTrials.gov